Table 3 Solicited adverse events - summary table
Subjects with 1 or more AEs: | Ad26/MVA | Ad26/Ad26 + gp140 | Placebo |
|---|---|---|---|
Analysis set: Full analysis set | 10 | 9 | 6 |
Post-Any Dose | 10 | 9 | 6 |
Solicited AEs | 10 (100.0%) | 9 (100.0%) | 5 (83.3%) |
Solicited AEs of grade 3 | 2 (20.0%) | 4 (44.4%) | 0 |
Solicited AEs of grade 4 | 0 | 0 | 0 |
Solicited local AEs | 9 (90.0%) | 8 (88.9%) | 4 (66.7%) |
Solicited local AEs of grade 3 | 1 (10.0%) | 0 | 0 |
Solicited local AEs of grade 4 | 0 | 0 | 0 |
Solicited systemic AEs | 9 (90.0%) | 8 (88.9%) | 4 (66.7%) |
Solicited systemic AEs of grade 3 | 1 (10.0%) | 4 (44.4%) | 0 |
Solicited systemic AEs of grade 4 | 0 | 0 | 0 |
Solicited systemic AE that is thought to be related to study vaccine | 9 (90.0%) | 8 (88.9%) | 4 (66.7%) |
Solicited systemic AE of at least grade 3 and that is thought to be related to study vaccine | 1 (10.0%) | 4 (44.4%) | 0 |
